'Treatment arm' diaporamas de présentation

Presented By Martine Piccart-Gebhart at 2014 ASCO Annual Meeting

First results from the phase III ALTTO trial (BIG 02-06; NCCTG 063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T?L) or their combination (L + T) in the adjuvant treatment of HER2-positive <br />early breast cancer (EBC).

478 views • 30 slides

Background

Individualizing Treatment Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: An Analysis from the DAPT Study.

193 views • 19 slides

Treatment arms Patients at risk Daunorubicin 330 225 175 160 150 138 126 112

Supplementary Figure 1. Cumulative incidences of complete remission according to the treatment arm. Supplementary Figure 2A. 7-year disease-free survival according to the treatment arm. Treatment arms Patients at risk Daunorubicin 330 225 175 160 150 138 126 112

124 views • 12 slides

Fenofibrate Intervention and Event Lowering in Diabetes

FIELD. Fenofibrate Intervention and Event Lowering in Diabetes. Presented at The American Heart Association Scientific Sessions, November 2005 Presented by Dr. Anthony Keech. FIELD: Background.

294 views • 10 slides

Eligible acute infarct patients

125 views • 1 slides